Nongenomic bile acid on smooth muscle BK channels
平滑肌 BK 通道上的非基因组胆汁酸
基本信息
- 批准号:7212256
- 负责人:
- 金额:$ 17.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdverse effectsAndrogensArteriesBile AcidsBindingBlood VesselsCell NucleusCellsCerebrovascular DisordersCerebrumChemical StructureChemicalsChemosensitizationCholesterolCloningComplementComplexDataDevelopmentDrug effect disorderElectrophysiology (science)EngineeringEnvironmentEstradiolExposure toFunctional disorderFutureGenomicsGoalsHormonalIn VitroIon ChannelLaboratoriesLateralLeadLengthLinkLithocholic AcidMeasuresMediator of activation proteinMembraneMethodologyModelingMolecularMolecular BiologyMolecular Biology TechniquesMuscleMuscle CellsMuscle TonusMuscle relaxation phaseMutagenesisOther FindingPatch-Clamp TechniquesPharmaceutical PreparationsPharmacologyPhysiologyProcessProgesteroneProtein RegionProteinsProteolipidsRattusRelaxationResolutionRoleSmooth MuscleSteroidsTestingTextTherapeuticTherapeutic UsesThinkingTissuesVascular DiseasesVascular Smooth MuscleVasodilationVasodilator AgentsXenopus oocyteanalogbasecerebral arterycerebrovasculardesignexperiencein vitro Modelin vivoinsightlarge-conductance calcium-activated potassium channelsnon-genomicpatch clampresearch studyresponsesteroid metabolism
项目摘要
DESCRIPTION (provided by applicant): Previous data from our laboratory demonstrated that acute exposure to cholane derivatives (bile acids and synthetic analogs) increases the activity of large conductance, Ca2+-sensitive K+ (BK) channels in arterial smooth muscle. Activation of smooth muscle BK channels is thought to be a major mechanism underlying vasodilation caused by not only bile acid derivatives, but also other physiologically relevant steroids, such as estradiol, progesterone, and androgens. In contrast, others and we found that increased cholesterol levels lead to smooth muscle BK channel inhibition. The long-term goal of this proposal is to identify both the structural determinants in the steroid molecule and the channel protein regions that are responsible for steroid activation of BK channels. Combining methodologies from Electrophysiology (patch-clamp), Molecular Biology, and Pharmacology, we will specifically address: 1) which chemical determinants in the cholane derivative molecule are critical for activating smooth muscle BK channels; 2) which channel subunit (alpha vs. beta) is necessary/sufficient for cholane derivative action; 3) which protein regions in the channel subunits are responsible for conferring cholane sensitivity to the ion channel complex; 4) whether modulation of BK channel activity by cholane derivatives underlies smooth muscle relaxation caused by these steroids. We will answer these questions going from studies in isolated arteries to evaluate drug action on tissue physiology to studies that used engineered ion channel subunits expressed in Xenopus oocytes to address the more mechanistic aspects of the application. We will initially use the rat cerebral artery to freshly isolate both a resistive artery segment to measure changes in tone caused by steroids, and dissociated myocytes to probe steroid modulation of native BK channels. The same overall strategy can be applied to other relevant vessels in the future. We chose the rat cerebral artery/myocyte model because: a) the key role of BK channel activity as regulator of arterial tone was clearly demonstrated; b) we have experience studying the effect of modulators on the active/passive tone of isolated rat cerebral arteries; c) we have isolated, cloned and successfully expressed in Xenopus oocytes the pore forming subunit of the rat cerebral artery BK channel; d) the therapeutic need for new cerebral vasodilators that act on the smooth muscle itself, i.e., that can be effective in the absence of intact endothelial function. Pinpointing the molecular mechanisms involved in the steroid-cerebrovascular BK channel interaction will bring fundamental insight for the rationale design of steroidal vasodilators of potential therapeutic use, devoid of hormonal side effects.
描述(由申请人提供):我们实验室以前的数据表明,急性暴露于胆烷衍生物(胆汁酸和合成类似物)会增加动脉平滑肌中大电导、Ca2+敏感K+ (BK)通道的活性。平滑肌BK通道的激活被认为是血管舒张的主要机制,不仅由胆汁酸衍生物引起,也由其他生理相关类固醇如雌二醇、黄体酮和雄激素引起。相比之下,其他人和我们发现胆固醇水平升高会导致平滑肌BK通道抑制。本提案的长期目标是确定类固醇分子中的结构决定因素和负责类固醇激活BK通道的通道蛋白区域。结合电生理学(膜片钳)、分子生物学和药理学的方法,我们将具体解决:1)胆烷衍生物分子中的哪些化学决定因素对激活平滑肌BK通道至关重要;2)哪个通道亚基(α与β)对于胆烷衍生物作用是必要/充分的;3)通道亚基中哪些蛋白质区域负责赋予胆碱对离子通道复合物的敏感性;4)胆烷衍生物是否对BK通道活性的调节是这些类固醇引起的平滑肌松弛的基础。我们将回答这些问题,从在孤立动脉中评估药物对组织生理学的作用的研究,到在非洲爪蟾卵母细胞中表达的工程离子通道亚基的研究,以解决应用的更多机制方面。我们将首先利用大鼠大脑动脉分离出一段新的抗阻动脉段来测量类固醇引起的张力变化,并分离出肌细胞来探测类固醇对天然BK通道的调节。未来,同样的整体策略也可以应用于其他相关船只。我们选择大鼠脑动脉/肌细胞模型是因为:a) BK通道活性作为动脉张力调节的关键作用已被清楚地证明;B)我们有经验研究调节剂对离体大鼠脑动脉主动/被动张力的影响;c)分离、克隆并在爪蟾卵母细胞中成功表达了大鼠脑动脉BK通道孔形成亚基;D)治疗需要对平滑肌本身起作用的新型脑血管扩张剂,也就是说,在没有完整内皮功能的情况下可以有效。明确类固醇-脑血管BK通道相互作用的分子机制将为潜在治疗用途的类固醇血管扩张剂的基本原理设计带来根本的见解,没有激素副作用。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Design and synthesis of hydroxy-alkynoic acids and their methyl esters as novel activators of BK channels.
羟基炔酸及其甲酯作为 BK 通道新型激活剂的设计和合成。
- DOI:10.1016/j.bmcl.2008.03.080
- 发表时间:2008
- 期刊:
- 影响因子:2.7
- 作者:Patil,Shivaputra;Bukiya,AnnaN;Li,Wei;Dopico,AlejandroM;Miller,Duane
- 通讯作者:Miller,Duane
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEX M. DOPICO其他文献
ALEX M. DOPICO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEX M. DOPICO', 18)}}的其他基金
Regulation of arterial diameter through specific sensing of endogenous steroids and novel nonsteroidal analogs by BK channel subunits
通过 BK 通道亚基对内源性类固醇和新型非类固醇类似物的特异性感应来调节动脉直径
- 批准号:
9894850 - 财政年份:2019
- 资助金额:
$ 17.02万 - 项目类别:
Regulation of arterial diameter through specific sensing of endogenous steroids and novel nonsteroidal analogs by BK channel subunits
通过 BK 通道亚基对内源性类固醇和新型非类固醇类似物的特异性感应来调节动脉直径
- 批准号:
10090627 - 财政年份:2019
- 资助金额:
$ 17.02万 - 项目类别:
Regulation of arterial diameter through specific sensing of endogenous steroids and novel nonsteroidal analogs by BK channel subunits
通过 BK 通道亚基对内源性类固醇和新型非类固醇类似物的特异性感应来调节动脉直径
- 批准号:
10364605 - 财政年份:2019
- 资助金额:
$ 17.02万 - 项目类别:
Vasodilation via selective pharmacological targeting of BK channel beta1 subunits
通过选择性药理学靶向 BK 通道 β1 亚基实现血管舒张
- 批准号:
7992134 - 财政年份:2010
- 资助金额:
$ 17.02万 - 项目类别:
Vasodilation via selective pharmacological targeting of BK channel beta1 subunits
通过选择性药理学靶向 BK 通道 β1 亚基实现血管舒张
- 批准号:
8277338 - 财政年份:2010
- 资助金额:
$ 17.02万 - 项目类别:
Vasodilation via selective pharmacological targeting of BK channel beta1 subunits
通过选择性药理学靶向 BK 通道 β1 亚基实现血管舒张
- 批准号:
8080805 - 财政年份:2010
- 资助金额:
$ 17.02万 - 项目类别:
Vasodilation via selective pharmacological targeting of BK channel beta1 subunits
通过选择性药理学靶向 BK 通道 β1 亚基实现血管舒张
- 批准号:
8600967 - 财政年份:2010
- 资助金额:
$ 17.02万 - 项目类别:
Nongenomic bile acid on smooth muscle BK channels
平滑肌 BK 通道上的非基因组胆汁酸
- 批准号:
6812493 - 财政年份:2004
- 资助金额:
$ 17.02万 - 项目类别:
Nongenomic bile acid on smooth muscle BK channels
平滑肌 BK 通道上的非基因组胆汁酸
- 批准号:
6891407 - 财政年份:2004
- 资助金额:
$ 17.02万 - 项目类别:
Nongenomic bile acid on smooth muscle BK channels
平滑肌 BK 通道上的非基因组胆汁酸
- 批准号:
7035827 - 财政年份:2004
- 资助金额:
$ 17.02万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 17.02万 - 项目类别:
Research Grant